BeyondSpring Stock Price

0.21 (18.58%)
Upgrade to Real-Time
Afterhours (Closed)
Volume 987,515
Bid Price 1.20
Ask Price 1.43
News -
Day High 1.47


52 Week Range


Day Low 1.20
Best deals to access real time data!
Ultimate Trader (Monthly)
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
Big Cap Pro
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
BeyondSpring Inc BYSI NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.21 18.58% 1.34 20:00:00
Open Price Low Price High Price Close Price Prev Close
1.25 1.20 1.47 1.32 1.13
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
4,367 987,515 $ 1.37 $ 1,348,126 - 1.13 - 33.00
Last Trade Time Type Quantity Stock Price Currency
19:42:46 33 $ 1.34 USD


Draw Mode:

BeyondSpring Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 40.86M 30.49M 23.09M $ 1.35M $ - -1.64 -0.70
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - - -

more financials information »

BeyondSpring News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical BYSI Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week1.361.471.131.19185,282-0.02-1.47%
1 Month1.631.751.131.40240,337-0.29-17.79%
3 Months2.152.711.131.94315,005-0.81-37.67%
6 Months15.2615.401.134.711,061,569-13.92-91.22%
1 Year10.5433.001.1317.041,507,947-9.20-87.29%
3 Years15.18533.001.1316.35595,773-13.85-91.18%
5 Years31.0448.491.1316.42366,867-29.70-95.68%

BeyondSpring Description

BeyondSpring Inc is engaged in clinical stage biopharmaceutical activities focused on the development of cancer therapies. It is also focused on including immuno-oncology agents. The Company has created Plinabulin which is marine derived small-molecule with a number of distinct biological activities that may provide multiple therapeutic opportunities. Plinabulin has increased the survival of neutrophils, a type of white blood cell important in the prevention of bacterial infections. The Company has a scalable business model integrating clinical resources in the United States and China.

Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.